From Alphastreet - Earnings Decoded. Market Intelligence Delivered · Newsdesk · · 1m
iRhythm Cyberattack Shifts Investor Focus
iRhythm's cyberattack disclosure turns data risk into investor catalyst.
In brief
iRhythm's cyberattack disclosure turns data risk into investor catalyst. iRhythm Technologies reported Q2 2026 revenue of $224.2 million with improved margins despite a cybersecurity incident that now requires patient notification. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Q2 2026 Results
iRhythm reported revenue of $224.2 million, up 20.1% year over year, in the quarter ended June 30, 2026.
Margin Progress
The company achieved a gross margin of 72.8% and adjusted EBITDA of $43.3 million in Q2 2026.
Cybersecurity Incident
iRhythm identified unauthorized data access on June 8, 2026, involving patient information and proprietary data.
Patient Notification Phase
The company began notifying impacted individuals after accessing data between June 3 and June 8, 2026.
Investor Guidance
Management raised 2026 revenue guidance to $880 million and adjusted EBITDA margin to 13.0% to 14.0%.
What Investors Should Watch
Investors must monitor demand stability, cost containment, and trust in iRhythm's cardiac monitoring platform.
What matters most
iRhythm Technologies reported Q2 2026 revenue of $224.2 million with improved margins despite a cybersecurity incident that now requires patient notification.
